Strain Profile
Save

Bifidobacterium bifidum R0071

◔ Human-origin
Sequenced
Public genome assembly available

Bifidobacterium bifidum strain R0071 is a gram-positive anaerobic bacterium native to the human gastrointestinal tract. Research includes animal studies of its immunomodulatory and mucin-regulating effects, in vitro investigation of its interactions with human milk oligosaccharides, and randomized controlled trials examining its associations with changes in gut microbiota, immune function, and gastrointestinal symptoms in infants and healthy adults.

Where it's been studied

Share of this strain's 20 body-system-tagged papers that concern each system. Research coverage, not measured effect.

Symptoms in the research

Share of this strain's 8 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

Research

24 papers reference this strain in the probiotic database.

Match confidence
2026 ANIMAL
Human Milk Oligosaccharide Synbiotic Alleviates Food Allergy in Mice by Modulating Gut Microbiota and Increasing Indole-3-lactic Acid Levels
· Journal of Agricultural and Food Chemistry
2025 OBSERVATIONAL
Early supplement of probiotics reduces the risk of obesity among preschool children: a real-world observational study
· Frontiers in Nutrition
2025 IN_VITRO
Mapping probiotic interactions with human milk oligosaccharides
·
2025 IN_VITRO
Bifidobacterial interactions with human milk oligosaccharides and their combined potential for the advancement of infant nutrition
· Cork Open Research Archive (University College Cork, Ireland)
2022 IN_VITRO
Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species
· Scientific Reports
2022 IN_VITRO
In Vitro Probiotic Modulation of the Intestinal Microbiota and 2′Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age
· Microorganisms
2020 RCT
O3 Changes in gut microbiota after synbiotic supplementation in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
· Oral Presentations
2019 RCT
Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study
· Beneficial Microbes
2018 RCT
Modulatory effect of three probiotic strains on infants’ gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study
· Beneficial Microbes
2017 IN_VITRO
Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination
· PLoS ONE
2017 RCT
Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial
· Beneficial Microbes
2016 RCT
Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial
· Beneficial Microbes
2015 RCT
Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study
· British Journal Of Nutrition
2014 RCT
Bifidobacterium bifidum R0071 decreases stress‐associated diarrhea‐related symptoms and ultimately self‐reported stress in a randomized, double‐blind, placebo‐controlled study (647.21)
· The FASEB Journal
2014 RCT
The proportion of stressed individuals who, on any given day, do not have a cold/flu may be increased by the intake of bifidobacteria: a randomized, double‐blind, placebo‐controlled study (639.13)
· The FASEB Journal
2013 IN_VITRO
Multistrain Probiotic Modulation of Intestinal Epithelial Cells' Immune Response to a Double-Stranded RNA Ligand, Poly(I·C)
· Applied and Environmental Microbiology
2010 OBSERVATIONAL
Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study
· Therapeutic Advances in Respiratory Disease
2010 ANIMAL
Immunomodulatory impact of a synbiotic in Th1 and Th2 models of infection
· Therapeutic Advances in Respiratory Disease
2005 ANIMAL
INTESTINAL MUCIN GENE MODULATION IN VIVO USING ORALLY ADMINISTERED PROBIOTIC BACTERIA
· Journal of Pediatric Gastroenterology and Nutrition
2026 RCT
Precision synbiotic intervention with 2′-fucosyllactose and infant-derived Bifidobacterium modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial
· Frontiers in Nutrition
Browse all 24 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Precision synbiotic intervention with 2′-fucosyllactose and infant-derived Bifidobacterium modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial
    · Frontiers in Nutrition · 2026
    PMID 42598364 →
  2. [2]
    Mapping probiotic interactions with human milk oligosaccharides
    · · 2025
    Source →
  3. [3]
    Bifidobacterium bifidum R0071 decreases stress‐associated diarrhea‐related symptoms and ultimately self‐reported stress in a randomized, double‐blind, placebo‐controlled study (647.21)
    · The FASEB Journal · 2014
    Source →